ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

Calamos Advisors LLC's Holding History (CIK: 0001316507)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 372,000 Value ($000) $549 Avg Close — Range —
Q3 2025
Shares 365,000 Value ($000) $602 Avg Close — Range —
Q2 2025
Shares 41,319,000 Value ($000) $53,804 Avg Close — Range —
Q1 2025
Shares 41,326,000 Value ($000) $47,701 Avg Close — Range —
Q4 2024
Shares 41,328,000 Value ($000) $44,130 Avg Close — Range —
Q3 2024
Shares 51,378,000 Value ($000) $60,191 Avg Close — Range —
Q2 2024
Shares 47,073,000 Value ($000) $50,749 Avg Close — Range —
Q1 2024
Shares 47,094,000 Value ($000) $44,222 Avg Close — Range —
Q4 2023
Shares 56,363,000 Value ($000) $55,866 Avg Close — Range —
Q3 2023
Shares 56,317,000 Value ($000) $52,344 Avg Close — Range —